Shingrix vial kits
Ended Awarded
- Contract number
- SPE2DB25FMZSJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,139
Award facts
- Contract value 100% obligated
- $1,139.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits on September 8, 2025, with a ceiling value of $1,139.18. The contract is non-competitive, firm fixed price, and scheduled for completion by September 9, 2025. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in adults, making this a critical pharmaceutical supply for military and veteran healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs through the Defense Logistics Agency's Medical Supply Chain.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is planning Generation V Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic partner in federal medical supply distribution.
Quick answers
Who was awarded contract SPE2DB25FMZSJ?
SPE2DB25FMZSJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FMZSJ worth?
The government has obligated $1,139 on SPE2DB25FMZSJ.
Is contract SPE2DB25FMZSJ an order under another contract?
Yes. SPE2DB25FMZSJ is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMZSJ competed?
The extent of competition for SPE2DB25FMZSJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award